TY  - JOUR
AN  - 067137790
PY  - 2011/01/01
TI  - Poster Impact of Prior Somatostatin Analog (Ssa) Use on Pfs in the Multicenter, Phase Iii Trial of Everolimus + Octreotide Lar Vs Placebo + Octreotide Lar in Patients With Advanced Neuroendocrine Tumours (Radiant-2)
JO  - European Journal of Cancer
VL  - 47
SP  - S462
EP  - S463
UR  - https://eurekamag.com/research/067/137/067137790.php
ER  -